December 2018 Vol 9, No 12
The number of people affected by cancer, both individuals diagnosed with the disease and their families and friends, is staggering. Although all individuals are at risk of a cancer diagnosis in their lifetime, there has been a remarkable reduction in deaths associated with cancer.
The prevalence of compassion fatigue is a critical reality for oncology nurses and lay navigators. The factors that contribute to, or help stave off, compassion fatigue have been studied by leading academic minds and by healthcare administrators.
The PD-L1 inhibitor durvalumab showed an overall survival benefit in patients with unresectable stage III non–small cell lung cancer (NSCLC) in the phase 3 PACIFIC trial.
Immunotherapy is one of the hottest concepts in oncology care. Also called biologic therapy, this type of cancer treatment boosts the body’s own natural defenses to fight cancers.
A female patient in her forties was diagnosed with a recurrence of leukemia. She was struggling through several issues as a single mother of 4 children, 2 of whom were disabled, before she found out about her cancer returning.
Results 1 - 6 of 6